NLRP3 inflammasome activation have been involved in various inflammatory diseases such as type 2 diabetes, atherosclerosis, gout, Alzheimer’s disease, and inflammatory bowel disease (IBD) [44–46]. Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.